Navigation Links
IRIDEX Granted U.S. Patent for Stepped Angled Laser Handpieces Used in Eye Surgery
Date:5/2/2011

MOUNTAIN VIEW, Calif., May 2, 2011 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that the U.S. Patent and Trademark Office had issued to IRIDEX a patent applying to a group of specially designed laser handpieces used in invasive ophthalmic surgical procedures. The patent, No. 7,909,816 and titled "Directional Probe Treatment Apparatus," applies to a number of consumable medical devices already in the IRIDEX product line collectively known as Stepped Angled EndoProbe® laser handpieces.

"This is an important patent for us because our Stepped Angled probes are the best selling product line within our consumable product portfolio," said IRIDEX President and CEO Theodore A. Boutacoff. "Users of these handpieces consistently comment on their performance, ease of use and their longer working distance compared to competitive probes. This patent helps us further differentiate our products from our competitors and creates new barriers for competition."

"Furthermore, we intend to expand our Stepped Angled EndoProbe product line by introducing additional versions," Boutacoff added. "This is another example of us executing on our ongoing goal of increasing the number of consumable devices we offer and to further grow our revenue in that high-margin category."

Stepped Angled EndoProbe handpieces are used in invasive ophthalmic surgical procedures. A portion of the outside diameter in these devices is both reduced in diameter and formed into an arc. The incorporation of both of these features in a single device gives ophthalmologists the clinical benefits of a curved laser probe while maintaining compatibility with the straight cannulas used with today's small-gauge vitrectomy instruments.

The patented Stepped Angled EndoProbe handpiece design offers some unique advantages over alternative angled probes. The handpieces are very durable and rea
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. IRIDEX Announces First Quarter 2011 Conference Call and Release Date
2. IRIDEX to Present at the Roth OC Growth Stock Conference in Dana Point, CA
3. IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter
4. IRIDEX to Present at the OneMedForum San Francisco 2011 Conference
5. IRIDEX Reports Improved Third Quarter 2010 Financial Results
6. IRIDEX Announces Third Quarter 2010 Conference Call and Release Date
7. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
8. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
9. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
10. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
11. IRIDEX Announces First Quarter 2010 Conference Call and Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 An experimental drug designed to help ... first treatment for anemia of inflammation, according to results from ... online today in Blood , the Journal ... Anemia is a condition that occurs when red ... properly. When an individual has anemia, the body does not ...
(Date:8/27/2014)... , Aug. 27, 2014  CVS Caremark (NYSE: ... a new clinical affiliation with MedStar Health, a leading ... Maryland and the Washington, DC ... affordable health care services for patients. Through this clinical ... to clinical support, medication counseling, chronic disease monitoring and ...
(Date:8/27/2014)... - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), ... for its third quarter of fiscal 2014: For ... Revenue of $1,291,378, a 13% decrease over the same period ... quarter of $240,156 compared to net income of $238,826 during ... For the nine months ended June 30, 2014: ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... Calif., Oct. 1 Accuray Incorporated (Nasdaq: ARAY ... announced today publication of results from a study of ... The study demonstrated that erectile function was preserved in ... two years. Published rates of erectile function preservation at ...
... Systems, a Hill-Rom company, (NYSE: HRC ), announces ... with top orthopaedic surgeons. Carlos A. Guanche, M.D., managing ... surgeon and is recognized for his contributions in expanding ... elbow fractures, scopes and clavicle repair procedures. , ...
Cached Medicine Technology:Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 2Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 3Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 4Allen Medical Systems Announces Surgeon Spotlight Series Interview 2Allen Medical Systems Announces Surgeon Spotlight Series Interview 3
(Date:8/27/2014)... (PRWEB) August 27, 2014 For nearly ... performances by the beloved mantra singers Deva Premal & ... Following the release of their latest album in May, ... down in twenty-two countries around the globe, including Russia, ... Argentina and across Europe. With a new album and ...
(Date:8/27/2014)... BESLER Consulting , a leading provider ... is pleased to announce that it has been named ... Companies. The list represents the most comprehensive look at ... , "It's been an exciting year for our company ... year's Inc. 5000 list,” said Jonathan Besler, BESLER’s President ...
(Date:8/27/2014)... August 27, 2014 Home Care ... care for seniors, is proud to announce the next ... upcoming webinar will feature Dr. Suzanne Steinbaum, attending cardiologist ... Hospital in New York City, National Spokesperson for the ... webinar will cover the issues surrounding women and heart ...
(Date:8/27/2014)... clinical trial participation in the largest ongoing observational study ... not representative of the larger patient base, according to ... Jay Udell. The study authors call into question the ... and suggest the use of broader enrollment criteria and ... know that clinical trials can be tremendously expensive and ...
(Date:8/27/2014)... (Lebanon, NH 8/27/14)Dartmouth cancer researchers developed and tested ... and environmental interactions that contribute to disease as ... , The approach fills a gap in ... from complex interactions among genetic and environmental factors. ... relevant interactions versus those that reflect chance combinations ...
Breaking Medicine News(10 mins):Health News:Deva Premal & Miten's Mantras For Life Tour Announced 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 3Health News:BESLER Consulting Among America’s Fastest Growing Private Companies 2Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Dartmouth isolates environmental influences in genome-wide association studies 2
... study, there is a connection between certain bacteria in ... of using probiotics to treat autism.// ... this study. Though the results are very preliminary, he ... propose any link between autism and childhood vaccinations. ...
... of medical tourism has created new vistas, enabling a ... world.// In the race for being the best in ... the industry’s powerful trident - Pharmaceutical Industry, Doctors and ... well as diseases”, said Karl Marx, and what better ...
... from Spain are not too comfortable with the outcome of ... grace//, could carry a risk of formation of fatal blood ... 2000 as an upgraded version of bare-metal stents. ... have the drug-lined versions of the stents, which are designed ...
... Attention Deficit Hyperactivity Disorder (ADHD) cannot sit calmly at ... health professionals and parents are familiar with the symptoms, ... topic. ,The FDA has given instructions that ... should put up warnings about the possible side effects ...
... James, the British chairman of the International Obesity Task ... the obesity epidemic in poor countries. ,"The ... which subsidize and distort the market to make fats ... James said at the 10th International Obesity Congress in ...
... 150th anniversary celebrations of Madras University, his alma mater ... institutions in India. ,Speaking on the occasion, ... "Good teaching emanates from research. Any university is judged ... academics here. ,He opened a virtual university ...
Cached Medicine News:Health News:Probiotics – a probable treatment for Autis 2Health News:Chemistry Over The Counter: Is It Just What The Doctor Ordered? 2Health News:Chemistry Over The Counter: Is It Just What The Doctor Ordered? 3Health News:Chemistry Over The Counter: Is It Just What The Doctor Ordered? 4Health News:Alternative therapies for ADHD 2Health News:Alternative therapies for ADHD 3Health News:President Launches Madras University's 150th Year Celebrations 2
9 mm diameter pigtail curved blunt probes. Stainless steel. Round knurled handle with polished finish. Includes pre-cut polyethylene tubes. Overall length: 5.9 inches....
12 mm diameter pigtail curved probes with eyes 4mm back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.9 inches....
The Novus 2000 argon laser combines power, size, and versatility. Ideal for the office, clinic and operating room environments, Novus 2000 is the world's most widely accepted ophthalmic laser....
The VISULAS 532s combines ease of use, efficiency and safety to provide ophthalmologists with an overall system sharply focused on their requirements. ,The VISULAS 532s is a laser of many talent...
Medicine Products: